CDTX vs DHR · rev $1.3M vs P/E 39, rev $24.57B
Cidara Therapeutics Inc (CDTX) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
CDTX currently screens at market cap $6.96B. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the CDTX and DHR stock pages for the full models.
Not investment advice.